Male Breast Carcinoma Recruiting Phase 2 Trials for Lapatinib (DB01259)

IndicationStatusPhase
DBCOND0030384 (Male Breast Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs